This site is intended for health professionals only

Strong growth forecast for Novartis

teaser

Analysts are predicting second-quarter net income growth for Novartis of 14%, to $1.88bn, on strong sales of Diovan






Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine

x